throbber
Paper No. 2
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`___________________
`
`APPLE INC.
`
`Petitioner,
`
`v.
`
`VIRNETX INC.,
`
`Patent Owner.
`
`
`Patent No. 6,502,135
`Issued: Dec. 31, 2002
`Filed: Feb. 15, 2000
`Inventors: Edmund C. Munger, et al.
`Title: AGILE NETWORK PROTOCOL FOR SECURE COMMUNICATIONS
`WITH ASSURED SYSTEM AVAILABILITY
`____________________
`
`Inter Partes Review No. IPR2016-00062
`__________________________________________________________________
`
`
`PETITIONER’S MOTION FOR JOINDER
`
`
`
`
`
`

`
`IPR2016-00062
`
`
`
`Motion for Joinder
`
`I.
`
`INTRODUCTION
`
`Petitioner Apple Inc. (“Apple”) moves to join its concurrently filed petition
`
`for inter partes review involving U.S. Patent No. 6,502,135 (the ’135 patent) with
`
`the inter partes review requested by the Mangrove Partners Master Fund, Ltd.
`
`(“Mangrove”) against the same patent, The Mangrove Partners Master Fund, Ltd.,
`
`v. VirnetX Inc., IPR2015-01046 (the Mangrove IPR). The Board instituted trial in
`
`that proceeding on October 7, 2015. Apple seeks to join as a party to the
`
`Mangrove IPR, and thus, has presented patentability challenges that are
`
`substantively the same as those presented by Mangrove. As explained in § III.C
`
`below, the sole difference is that, with this petition, Apple is submitting several
`
`additional exhibits that supplement the information in the Mangrove IPR record
`
`that shows that RFC 1034 is prior art to the ’135 patent.
`
`The Apple petition is timely filed under 35 U.S.C. § 315(c), as it is filed
`
`within one month of the date that the Mangrove IPR was instituted. See IPR2015-
`
`01046, Paper 11 at 1, 12. As the statute provides and the Board has explained, the
`
`one-year filing window specified in § 315(b) and § 42.101(b) “shall not apply to a
`
`request for joinder under subsection (c).” 35 U.S.C. § 315(b); Dell Inc. v.
`
`Network-1 Security Solutions, Inc., IPR2013-00385, Paper 17 at 4-5 (granting
`
`joinder beyond the one-year window); Microsoft Corp. v. Proxyconn, Inc.,
`
`IPR2013-00109, Paper 15 at 4-5 (same); 37 C.F.R. § 42.122(b) (the “time period
`
`- 1 -
`
`

`
`IPR2016-00062
`
`
`
`Motion for Joinder
`
`set forth in §42.101(b) shall not apply when the petition is accompanied by a
`
`request for joinder.”).
`
`Joinder is appropriate because of the substantial similarity between the
`
`Apple petition and the Mangrove IPR. The Apple petition relies on the same
`
`grounds as those instituted by the Board in the Mangrove IPR. Other factors
`
`relevant to joinder favor granting this motion, including that: (i) the same schedule
`
`for various proceedings can be adopted, (ii) Apple is not advancing any new expert
`
`testimony, and thus, discovery will not be impacted by joinder, and (iii) joinder
`
`will not materially affect the range of issues needing to be addressed by the Board
`
`and by the parties in the joined proceedings. See Kyocera Corp. v. Softview LLC,
`
`IPR2013-00004, Paper No. 15 at 4 (Apr. 24, 2013). Moreover, Apple is involved
`
`in other proceedings involving the ’135 patent and other patents in the ’135 patent
`
`family that involve some of the same art at issue here, and has an interest in
`
`ensuring the Board does not resolve an issue in this proceeding that would impact
`
`those other proceedings. Because these factors support joining these proceedings,
`
`Apple requests the Board to grant this motion for joinder.
`
`II. RELEVANT FACTS
`The ’135 patent is a member of a family of patents owned by VirnetX. See
`
`Apple Pet. at § I.C.2. The specifications of these patents are nearly identical.
`
`- 2 -
`
`

`
`IPR2016-00062
`
`
`
`Motion for Joinder
`
`VirnetX has asserted varying sets of claims of the ’135 patent and other of its
`
`patents against Apple and other entities in numerous lawsuits.
`
`In August of 2010, VirnetX sued Apple and five other entities (the “2010
`
`Litigation”). VirnetX asserted “at least” claims 1, 3, 7, 8, 9, 10, and 12 of the ’135
`
`patent against Apple. After trial, VirnetX obtained a judgment of infringement
`
`against Apple on, inter alia, claims 1, 3, 7, and 8 of the ’135 patent. On December
`
`31, 2012, VirnetX served a new complaint on Apple asserting infringement of “at
`
`least” claims 1, 3, 7, 8, 9, 10, and 12 of the ’135 patent, and leading to a civil
`
`action now pending in the Eastern District of Texas (the “2012 Litigation”). On
`
`September 16, 2014, the 2010 Litigation judgment was reversed-in-part by a
`
`Federal Circuit panel and remanded for a new trial on damages. See VirnetX, Inc.
`
`v. Cisco Systems, Inc., 767 F.3d 1308, 1313-14 (Fed. Cir. 2014). Both the
`
`remanded 2010 Litigation and the 2012 Litigation are scheduled for a consolidated
`
`trial in January of 2016.
`
`III. ARGUMENT
`Joinder with the Mangrove IPR is justified because each factor identified by
`
`the Board as supporting joinder is met. For example, the Board has explained that
`
`a motion for joinder should: (1) explain the reasons why joinder is appropriate; (2)
`
`identify any new grounds of unpatentability asserted in the petition; (3) explain
`
`what impact (if any) joinder would have on the trial schedule for the existing
`
`- 3 -
`
`

`
`IPR2016-00062
`
`
`
`Motion for Joinder
`
`review; and (4) address specifically how briefing and discovery may be simplified.
`
`Kyocera Corp. v. Softview LLC, IPR2013-00004, Paper 15 at 4 (representative
`
`order). Each of these factors is addressed below, and, when considered together,
`
`strongly support granting this motion for joinder.
`
`Joinder Is Appropriate
`
`A.
`Joinder between the instant petition and the Mangrove IPR is appropriate
`
`because they involve the same patent, the same art, the same expert declaration,
`
`and the same arguments and legal rationales. Apple’s proposed grounds of
`
`invalidity are identical to Mangrove’s.
`
`Permitting joinder will not prejudice Mangrove or VirnetX. Apple raises no
`
`issues that are not already before the Board, and consequently, joinder would not
`
`affect the timing of the Mangrove IPR nor the content of any of VirnetX’s
`
`responses. Moreover, Apple is amenable to coordinating with Mangrove and, as
`
`such, neither Mangrove nor VirnetX will suffer any additional costs or burdens in
`
`preparing motions and arguments.
`
`The denial of joinder, however, will prejudice Apple. Absent joinder, the
`
`petition would be untimely under § 315(b) and Apple would be unable to
`
`participate in the inter partes review proceeding related to the ’135 patent. Apple
`
`is involved in other proceedings involving the ’135 patent and other patents in the
`
`’135 patent family that involve some of the same art at issue here. Specifically,
`
`- 4 -
`
`

`
`IPR2016-00062
`
`
`
`Motion for Joinder
`
`Apple is the third party requester in inter partes reexamination proceedings
`
`involving the ’135 patent. See Control No. 95/001,682.1 These proceedings are
`
`based on a petition Apple filed in 2011, but remain pending now more than four
`
`years later, and despite the claims having been rejected repeatedly as
`
`unpatentable.2 Granting joinder would allow Apple to ensure the Board does not
`
`resolve an issue in this proceeding that would impact those other proceedings.
`
`Accordingly, because of the strong similarity of the instant petition to the
`
`Mangrove IPR, and to avoid prejudice to Apple, joinder is appropriate.
`
`B. No New Grounds of Unpatentability in the Apple Petitions
`Apple’s petition proposes institution of trial on the same grounds that were
`
`instituted by the Board in the Mangrove IPR, and Apple relies on the same exhibits
`
`1 Control No. 95/001,682 was filed on July 11, 2011. On October 15, 2015,
`
`Virnetx filed a Notice of Appeal in response to the Examiner’s Right of Appeal
`
`Notice rejecting claims 1-18 as unpatentable.
`
`2 The delays in the ’682 proceeding are largely due to the extraordinary number of
`
`petitions that Patent Owner VirnetX has filed in that proceeding. These petitions
`
`have sought, inter alia, to suspend the reexamination proceedings, delay the due
`
`dates applicable to VirnetX for filing each of its papers, or to have the Office
`
`reverse actions it has taken during the proceeding, including petitions seeking
`
`reconsideration of denials of earlier petitions by VirnetX.
`
`- 5 -
`
`

`
`IPR2016-00062
`
`
`
`Motion for Joinder
`
`and expert testimony included in the Mangrove IPR. In addition to those exhibits,
`
`Apple provides Exhibits 1026 to 1030 as supplemental evidence that is relevant to
`
`the prior art status of RFC 1034, one of the prior art references at issue in the
`
`Mangrove IPR. See Apple Pet. at § V. As the Board has found in other contexts,
`
`additional evidence of public availability does not change the grounds of
`
`unpatentability in a proceeding nor the evidence presented to support those
`
`grounds. See Palo Alto Networks, Inc v. Juniper Networks, Inc., IPR2013-00369,
`
`Paper 37 at 3 (Feb. 5, 2014). Instead, Exhibits 1026 to 1030 merely supplement
`
`the information presented in the Mangrove IPR and further support the Board’s
`
`preliminary findings. Accordingly, Apple proposes no new grounds of
`
`unpatentability.
`
`C. No Impact on the Trial Schedule of Costs of the Proceeding
`Granting this motion for joinder will have no impact on the trial schedule
`
`because Apple does not raise any issues that are not already before the Board.
`
`VirnetX does not need to specifically address any issues raised by Apple, and thus,
`
`joinder would have no impact on the cost of the proceeding. In addition, Apple is
`
`willing to adhere to the schedule already established for IPR2015-01046. See, e.g.
`
`Motorola Mobility LLC v. Softview LLC, IPR2013-000256, Paper 10 at 2-3 (June
`
`20, 2013) (identifying “impact of the joinder on the schedule and costs of the
`
`proceeding” as a factor relevant to decide whether to join proceedings).
`
`- 6 -
`
`

`
`IPR2016-00062
`
`
`
`Motion for Joinder
`
`Additionally, consideration of Apple’s additional evidence related to the
`
`prior art status of RFC 1034 will: (1) have no impact on the trial schedule and (2)
`
`not prejudice VirnetX. First, the Board’s rules authorize the submission of
`
`relevant supplemental information within one month after trial is instituted. See 37
`
`C.F.R. § 42.123(a). Each of exhibits 1026 to 1030 could be submitted in the
`
`Mangrove IPR as supplemental information under Section 42.123(a) because each
`
`(1) has been submitted within one month of institution, and (2) is relevant to a
`
`claim for which the trial has been instituted. See Palo Alto, IPR2013-00369, Paper
`
`37 at 3; see also Biomarin Pharma. Inc., v. Genzyme Therapeutic Prods Limited
`
`Partnership, IPR2013-00534, Paper 80 at 5 (Jan. 7, 2015) (more than one month
`
`after institution of a proceeding, finding that it was in the interests-of-justice to
`
`admit supplemental information on a reference’s publication date). As described
`
`above, the additional evidence provided with Apple’s petition does not change the
`
`grounds of unpatentability authorized for trial and does not alter the prior art that
`
`supports those grounds. Consideration of the additional evidence by the Board and
`
`the parties, thus, will have no impact on the trial schedule.
`
`Second, VirnetX will have limited need (if any) to investigate the proffered
`
`information because VirnetX already investigated most of the exhibits during one
`
`of the concurrent litigation proceedings. For example, VirnetX received Ms.
`
`Ginoza’s declaration and RFC 1034 (Exs. 1026-27) as part of a Section 337 action
`
`- 7 -
`
`

`
`IPR2016-00062
`
`
`
`Motion for Joinder
`
`in 2013, and it had the opportunity to cross-examine Ms. Ginoza about RFC 1034’s
`
`publication date. See Ex. 1028 at 50:7-69:1. Moreover, even if VirnetX feels it
`
`would be necessary to further investigate these exhibits, it is early in the discovery
`
`period of the Mangrove IPR and the IPR rules contemplate that a patent owner
`
`may need to consider relevant supplemental information submitted within one
`
`month of trial institution. See 37 C.F.R. § 42.123(a). Therefore, granting this
`
`motion for joinder will have no impact on the trial schedule.
`
`Proposals for Briefing in the Joined Proceedings
`
`D.
`Joinder will simplify briefing in both the Mangrove IPR and the present
`
`proceeding by eliminating the need for VirnetX to respond to substantially
`
`identical petitions twice. In the interest of efficiency, Apple is willing to
`
`coordinate with Mangrove to provide consolidated filings within the page limits set
`
`forth in the rules governing this proceeding so long as Mangrove is actively
`
`participating in the proceeding, or to accept other reasonable conditions on the
`
`conduct of the joined proceeding. In addition, Apple has not filed a separate expert
`
`declaration, and thus, VirnetX will not need to depose any additional witnesses.
`
`Apple is also willing to coordinate with Mangrove to avoid duplicative cross-
`
`examination of VirnetX expert witnesses.
`
`- 8 -
`
`

`
`IPR2016-00062
`
`
`
`Motion for Joinder
`
`IV. Conclusion
`Because the factors relevant to grant of a motion for joinder strongly support
`
`joining the present proceeding to IPR2015-01046, Apple requests this motion for
`
`joinder be granted.
`
`Dated: October 26, 2015
`
`
`
`
`
`Respectfully Submitted,
`
`/Jeffrey P. Kushan/
`Jeffrey P. Kushan
`(Reg No. 43,401)
`Sidley Austin LLP
`1501 K Street NW
`Washington, DC 20005
`jkushan@sidley.com
`
`
`
`- 9 -
`
`

`
`IPR2016-00062
`
`
`
`Motion for Joinder
`
`
`CERTIFICATE OF SERVICE
`
`I hereby certify that on this 26th day of October 2015, a copy of this Motion
`for Joinder, has been served in its entirety by Federal Express on the following
`counsel of record for VirnetX:
`
`VirnetX Inc.
`P.O. Box 439
`Zephyr Cove, Nevada 89448
`Patent Owner
`
`
`Abraham Kasdan
`Wiggin and Dana LLP
`450 Lexington Avenue
`New York, NY 10017
`Counsel of record for Petitioner in
`IPR2015-01047
`
`James T. Bailey
`504 W. 136th St., #1B
`New York, NY 10031
`Counsel of record for Petitioner in
`IPR2015-01047
`
`Respectfully submitted,
`
`/Jeffrey P. Kushan/
`Jeffrey P. Kushan
`Reg. No. 43,401
`
`Finnegan, Henderson, Farabow,
`Garrett & Dunner, LLP
`901 New York Avenue, NW
`Washington, DC 20001-4413
`Counsel of record for Patent Owner
`
`Joseph E. Palys
`Naveen Modi
`Paul Hastings LLP
`875 15th Street, NW
`Washington, D.C. 20005
`Counsel of record for Patent Owner
`in IPR2015-01047
`
`
`
`
`
`
`Dated: October 26, 2015

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket